Company news
Somnomed Limited (ASX:SOM) news
Somnomed Limited news releases on 6ix. Latest, Sep 21, 2016: FDA 510k approval for SomnoDent Alpha
Press releases — page 3
FDA 510k approval for SomnoDent Alpha
September 21, 2016
Strong finish to the financial year for SomnoMed
July 21, 2016
Derek Smith appointed Global CEO of SomnoMed
July 18, 2016
Results of Institutional Entitlement Offer
May 4, 2016
Chairmans Letter
May 2, 2016
Continuing High Growth in the Third Quarter
April 20, 2016
SomnoMed continues to break records in 4th Quarter
March 30, 2016
30% growth of direct sales revenues of Somnodent devices
February 11, 2016
SomnoMed exceeds 250,000 patients
February 10, 2016